基于FDG代谢参数的模型预测同时性结直肠癌肝转移术后复发
本研究开发并验证了基于FDG PET-CT代谢参数(转移灶与原发灶摄取比M/P ratio)的术后和术前模型,用于预测可切除同时性结直肠癌肝转移患者根治术后复发。多中心回顾性研究显示两模型外部验证时间依赖AUC均为0.76,显著高于Fong临床风险评分(0.65),校准良好且临床有用。模型以网页计算器和列线图呈现。
要点
- FDG PET-CT代谢参数M/P ratio联合临床病理因素可预测SCLM术后复发。
- 术后和术前模型外部验证AUC均为0.76,优于Fong评分(0.65)。
- 模型提供网页计算器和列线图,便于风险分层和临床决策。
局限性
- 回顾性研究设计。
- 原文未报告其他明显局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to develop and validate post- and preoperative models for predicting recurrence after curative-intent surgery using an FDG PET-CT metabolic parameter to improve the prognosis of patients with synchronous colorectal cancer liver metastasis (SCLM).
METHODS: In this retrospective multicenter study, consecutive patients with resectable SCLM underwent upfront surgery between 2006 and 2015 (development cohort) and between 2006 and 2017 (validation cohort). In the development cohort, we developed and internally validated the post- and preoperative models using multivariable Cox regression with an FDG metabolic parameter (metastasis-to-primary-tumor uptake ratio [M/P ratio]) and clinicopathological variables as predictors. In the validation cohort, the models were externally validated for discrimination, calibration, and clinical usefulness. Model performance was compared with that of Fong's clinical risk score (FCRS).
RESULTS: A total of 374 patients (59.1 ± 10.5 years, 254 men) belonged in the development cohort and 151 (60.3 ± 12.0 years, 94 men) in the validation cohort. The M/P ratio and nine clinicopathological predictors were included in the models. Both postoperative and preoperative models showed significantly higher discrimination than FCRS (p < .05) in the external validation (time-dependent AUC = 0.76 [95% CI 0.68-0.84] and 0.76 [0.68-0.84] vs. 0.65 [0.57-0.74], respectively). Calibration plots and decision curve analysis demonstrated that both models were well calibrated and clinically useful. The developed models are presented as a web-based calculator ( https://cpmodel.shinyapps.io/SCLM/ ) and nomograms.
CONCLUSIONS: FDG metabolic parameter-based prognostic models are well-calibrated recurrence prediction models with good discriminative power. They can be used for accurate risk stratification in patients with SCLM.
KEY POINTS: • In this multicenter study, we developed and validated prediction models for recurrence in patients with resectable synchronous colorectal cancer liver metastasis using a metabolic parameter from FDG PET-CT. • The developed models showed good predictive performance on external validation, significantly exceeding that of a pre-existing model. • The models may be utilized for accurate patient risk stratification, thereby aiding in therapeutic decision-making.
引用
- Lee, Kwon, Lim, et al. FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis. Eur Radiol. 2022. PMID: 36114846. doi:10.1007/s00330-022-09141-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。